Welcome to inVentiv Health investor relations
About inVentiv Health
inVentiv Health, Inc., is privately owned by inVentiv Group Holdings, Inc., an organization sponsored by affiliates of Thomas H. Lee Partners, L.P., Liberty Lane Partners, and members of the inVentiv Health management team.
Our growing client roster includes more than 550 pharmaceutical, biotech and life sciences companies. With 13,000 employees servicing clients in 70 countries, inVentiv supports clients across every part of a product’s lifecycle, from the inception of an idea through the development, launch, commercialization and maturity of a medical therapy or device.
We meet the industry’s growing interest in outsourcing by allowing clients to focus on what they do best and leave the rest to an efficient, fast-moving, and seamless team with unmatched expertise in Clinical, Commercial and Consulting services. Our leading industry experts help clients overcome clinical and regulatory challenges, anticipate commercialization issues, reduce costs, improve outcomes and make the most of promising business opportunities.
inVentiv Health, Inc. ("inVentiv") is privately held and does not make its financial information available to the public. However, (i) holders of our debt securities, (ii) certain prospective holders of our debt securities, (iii) securities analysts who cover or intend to cover inVentiv and our debt securities, and (iv) market makers who regularly make or intend to cover inVentiv and our debt securities may request access to the secured area, on which inVentiv provides annual and quarterly reports and certain other information relating to its business, by following the instructions available here.
If you already have a login, username and password, access the site now
Please return completed forms to:
inVentiv Health, Inc.
Attention: Investor Relations
1 Van de Graaff Drive
Burlington, MA 01803
For more information, please contact:
The company regularly distributes press releases on significant announcements. Visit our Newsroom